Form 8-K · Current Report · Filed 2024-10-31
The Cigna Group Reports Strong Third Quarter 2024 Results, Reaffirms 2024 Outlook
The Cigna Group reported robust financial results for the third quarter of 2024, with total revenues increasing by 30% to $63.7 billion, driven by significant growth in Evernorth Health Services.
- Filer
- The Cigna Group CI · NYSE
- Filed
- Accession
- 0001140361-24-044674
- CIK
- 0001739940
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
Adjusted income from operations was $2.1 billion, a 5% increase from the prior year. The company also reaffirmed its 2024 outlook for adjusted income from operations of at least $28.40 per share, factoring in expected share repurchases and dividends. Key contributors to the performance included strong growth in pharmacy revenues and specialty volume. Despite a non-cash after-tax investment loss of $1.0 billion related to VillageMD, the company’s shareholders' net income was $0.7 billion, or $2.63 per share.
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$312.89
Next session
+1.2%
Since filing
-10.8%
Latest close
$279.05
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CI reporting the same item, with the next session's move:
Exhibits (1)
About The Cigna Group
The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}
Never miss another CI filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.